[Form 4] Accenture PLC Insider Trading Activity

Rhea-AI Filing Summary

Accenture plc (ACN) director Tracey Thomas received a grant of restricted share units (RSUs) tied to prior awards to reflect a cash dividend. The Form 4 shows a transaction dated 08/15/2025 recorded as an acquisition (code A) with a reference price of $247.57. Following the reported transaction the filing lists 8,573 Class A ordinary shares beneficially owned. The filing was signed on behalf of Tracey Thomas by an attorney-in-fact on 08/18/2025. The explanatory note states the grant resulted from anti-dilution provisions of previously granted RSU awards to reflect Accenture's dividend payment.

Positive

• Director ownership disclosed: the filing reports 8,573 Class A shares beneficially owned after the transaction, improving insider alignment with shareholders.
• Clear disclosure of compensation adjustment: the explanatory note states the RSU grant was an anti-dilution adjustment to reflect a cash dividend, which clarifies the nature of the acquisition.

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received RSUs converted to shares due to anti-dilution adjustments tied to a cash dividend; transaction size is modest.

The Form 4 documents a routine insider acquisition through anti-dilution RSU adjustments rather than a market purchase. The filing shows a reference price of $247.57 and reports 8,573 Class A ordinary shares beneficially owned following the transaction. This is an equity compensation technical adjustment tied to dividend treatment and does not reflect direct open-market buying or selling. For investors, this is procedural and generally neutral for valuation absent larger context on total insider holdings or other material events.

Corporate Governance Expert

TL;DR: Anti-dilution RSU grant to a director is a standard compensation adjustment after a dividend; disclosure is timely and complete on Form 4.

The filing identifies Tracey Thomas as a director and records an acquisition under the anti-dilution terms of previously granted RSUs to reflect Accenture's cash dividend. The form is filed by one reporting person and signed by an attorney-in-fact, which is acceptable practice. This disclosure fulfills Section 16 reporting requirements and signals routine governance of equity awards rather than an extraordinary governance event.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Travis Tracey Thomas

(Last) (First) (Middle)

C/O ACCENTURE

500 W. MADISON STREET

(Street)

CHICAGO IL 60661

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Accenture plc [ ACN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A ordinary shares	08/15/2025		A		7(1)	A	$247.57	8,573	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of Restricted Share Units (RSUs) pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend.

Remarks:

	/s/ Danika Haueisen, Attorney-in-Fact for Tracey Thomas Travis	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Tracey Thomas report on the Form 4 for ACN?

The Form 4 reports an acquisition (code A) dated 08/15/2025 related to restricted share units (RSUs) adjusted for a cash dividend.

How many Accenture (ACN) shares are reported as beneficially owned after the transaction?

The filing lists 8,573 Class A ordinary shares beneficially owned following the reported transaction.

What price is shown on the Form 4 for the reported transaction?

The Form 4 shows a reference price of $247.57 associated with the reported acquisition.

What is the stated reason for the RSU grant on the Form 4?

The explanatory note states the grant was made pursuant to anti-dilution provisions of previously granted RSU awards to reflect Accenture plc's payment of a cash dividend.

Who signed the Form 4 and when was it signed?

The Form 4 is signed by Danika Haueisen, Attorney-in-Fact for Tracey Thomas with a signature date of 08/18/2025.